In this episode, Lilian Abbo, MD, FIDSA; Julie Ann Justo, PharmD, MS; and David van Duin, MD, PhD, FIDSA, FAST, discuss key concepts about extraintestinal pathogenic Escherichia coli, including:Diverse strains and virulence factors associated with invasive diseaseAntimicrobial resistance profiles seen in clinical practiceVarious disease manifestationsPrevalence and burden of invasive infectionsPopulations at riskRisk factors for multidrug-resistant strainsEmerging vaccine technologiesActive clinical trials Benefits of vaccines and the challenges associated with developmentImportance of antimicrobial stewardship and potential role of vaccines to reduce antimicrobial resistanceProgram Director: Lilian Abbo, MD, FIDSAAssociate Chief Medical Officer in Infectious DiseasesJackson Health SystemProfessor of Infectious DiseasesDepartment of Medicine & Miami Transplant InstituteUniversity of Miami Miller School of MedicineMiami, FloridaFaculty:Julie Ann Justo, PharmD, MSClinical Associate ProfessorDepartment of Clinical Pharmacy and Outcomes SciencesUniversity of South Carolina College of PharmacyInfectious Diseases Clinical Pharmacy SpecialistDepartment of PharmacyPrisma Health Richland HospitalColumbia, South CarolinaDavid Van Duin, MD, PhD, FIDSA, FASTProfessor of Medicine Director, Immunocompromised Host Infectious Diseases ProgramDivision of Infectious DiseasesUniversity of North CarolinaChapel Hill, North CarolinaContent based on a CME program supported by an educational grant from Janssen Therapeutics.Follow along with a downloadable slideset at:https://bit.ly/3eG29BnLink to full program:https://bit.ly/3eFHfCl Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related